BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32289280)

  • 21. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
    Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
    Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome.
    Lee H; Oh JY; Sung YA; Chung H; Kim HL; Kim GS; Cho YS; Kim JT
    Hum Reprod; 2015 Mar; 30(3):723-31. PubMed ID: 25574032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.
    Dapas M; Lin FTJ; Nadkarni GN; Sisk R; Legro RS; Urbanek M; Hayes MG; Dunaif A
    PLoS Med; 2020 Jun; 17(6):e1003132. PubMed ID: 32574161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome.
    Alan Harris R; Archer KJ; Goodarzi MO; York TP; Rogers J; Dunaif A; McAllister JM; Strauss JF
    Gene; 2023 Feb; 852():147062. PubMed ID: 36423778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome.
    Vicente ALSA; Marqui ABT; Gomes MKO; Assunção-Luiz AV; Balarin MAS; Tanaka SCSV; Resende EAMR; Lima MFP; Cintra MTR
    Rev Assoc Med Bras (1992); 2022; 68(6):785-791. PubMed ID: 35766692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
    Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies.
    Joo YY; Actkins K; Pacheco JA; Basile AO; Carroll R; Crosslin DR; Day F; Denny JC; Velez Edwards DR; Hakonarson H; Harley JB; Hebbring SJ; Ho K; Jarvik GP; Jones M; Karaderi T; Mentch FD; Meun C; Namjou B; Pendergrass S; Ritchie MD; Stanaway IB; Urbanek M; Walunas TL; Smith M; Chisholm RL; Kho AN; Davis L; Hayes MG;
    J Clin Endocrinol Metab; 2020 Jun; 105(6):1918-36. PubMed ID: 31917831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic Ovary Syndrome in Adolescents.
    Witchel SF; Roumimper H; Oberfield S
    Endocrinol Metab Clin North Am; 2016 Jun; 45(2):329-44. PubMed ID: 27241968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records.
    Actkins KV; Singh K; Hucks D; Velez Edwards DR; Aldrich M; Cha J; Wellons M; Davis LK
    J Clin Endocrinol Metab; 2021 Jan; 106(1):153-167. PubMed ID: 32961557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women.
    Cui L; Zhao H; Zhang B; Qu Z; Liu J; Liang X; Zhao X; Zhao J; Sun Y; Wang P; Li T; Shi Y; Chen ZJ
    Hum Reprod; 2013 Feb; 28(2):538-44. PubMed ID: 23208300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.
    Goodarzi MO; Louwers YV; Taylor KD; Jones MR; Cui J; Kwon S; Chen YD; Guo X; Stolk L; Uitterlinden AG; Laven JS; Azziz R
    Fertil Steril; 2011 Apr; 95(5):1736-41.e1-11. PubMed ID: 21300347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trp28Arg/Ile35Thr LHB gene variants are associated with elevated testosterone levels in women with polycystic ovary syndrome.
    Batista MC; Duarte Ede F; Borba MD; Zingler E; Mangussi-Gomes J; dos Santos BT; de Moraes OL; Hayashida SA; Baracat EC; da Rocha Neves Fde A; Maciel GA; Bachega TA; Barra GB; Lofrano-Porto A
    Gene; 2014 Oct; 550(1):68-73. PubMed ID: 25111116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.
    Jiang LL; Xie JK; Cui JQ; Wei D; Yin BL; Zhang YN; Chen YH; Han X; Wang Q; Zhang CL
    Medicine (Baltimore); 2017 Jan; 96(2):e5768. PubMed ID: 28079802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome.
    Li T; Zhao H; Zhao X; Zhang B; Cui L; Shi Y; Li G; Wang P; Chen ZJ
    J Med Genet; 2012 Apr; 49(4):254-7. PubMed ID: 22499345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.